<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://pedpalascnetlibrary.omeka.net/items/browse?tags=diamorphine&amp;sort_field=Dublin+Core%2CCreator&amp;output=omeka-xml" accessDate="2026-03-17T02:51:24-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="17573" public="1" featured="1">
    <collection collectionId="73">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="132276">
                  <text>June 2021 List</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>Citation List Month</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="132466">
              <text>June 2021 List</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="132474">
              <text>&lt;a href="http://doi.org/10.1177/02692163211008737" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/​10.1177/02692163211008737&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="132467">
                <text>Healthcare professionals' views of the use of oral morphine and transmucosal diamorphine in the management of paediatric breakthrough pain and the feasibility of a randomised controlled trial: A focus group study (DIPPER)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="132468">
                <text>Palliative Medicine.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="132469">
                <text>2021</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="132470">
                <text>Breakthrough pain; diamorphine; focus groups; opioids; paediatrics; pain management; palliative care; terminal care</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="132471">
                <text> Jamieson L; Harrop E; Johnson M; Liossi C; Mott C; Oulton K; Skene SS; Wong ICK; Howard RF</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="132472">
                <text>Background: Oral morphine is frequently used for breakthrough pain but the oral route is not always available and absorption is slow. Transmucosal diamorphine is administered by buccal, sublingual or intranasal routes, and rapidly absorbed. Aim(s): To explore the perspectives of healthcare professionals in the UK caring for children with life-limiting conditions concerning the assessment and management of breakthrough pain; prescribing and administration of transmucosal diamorphine compared with oral morphine; and the feasibility of a comparative clinical trial. Design/ participants: Three focus groups, analysed using a Framework approach. Doctors, nurses and pharmacists (n = 28), caring for children with life-limiting illnesses receiving palliative care, participated. Result(s): Oral morphine is frequently used for breakthrough pain across all settings; with transmucosal diamorphine largely limited to use in hospices or given by community nurses, predominantly buccally. Perceived advantages of oral morphine included confidence in its use with no requirement for specific training; disadvantages included tolerability issues, slow onset, unpredictable response and unsuitability for patients with gastrointestinal failure. Perceived advantages of transmucosal diamorphine were quick onset and easy administration; barriers included lack of licensed preparations and prescribing guidance with fears over accountability of prescribers, and potential issues with availability, preparation and palatability. Factors potentially affecting recruitment to a trial were patient suitability and onerousness for families, trial design and logistics, staff time and clinician engagement. Conclusion(s): There were perceived advantages to transmucosal diamorphine, but there is a need for access to a safe preparation. A clinical trial would be feasible provided barriers were overcome. Copyright © The Author(s) 2021.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="132473">
                <text>&lt;a href="http://doi.org/10.1177/02692163211008737" target="_blank" rel="noreferrer noopener"&gt;10.1177/02692163211008737&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="132475">
                <text>Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="35436">
        <name>2021</name>
      </tag>
      <tag tagId="26299">
        <name>Breakthrough Pain</name>
      </tag>
      <tag tagId="36710">
        <name>diamorphine</name>
      </tag>
      <tag tagId="1048">
        <name>Focus Groups</name>
      </tag>
      <tag tagId="1650">
        <name>Harrop E</name>
      </tag>
      <tag tagId="3819">
        <name>Howard RF</name>
      </tag>
      <tag tagId="4426">
        <name>Jamieson L</name>
      </tag>
      <tag tagId="36711">
        <name>Johnson M</name>
      </tag>
      <tag tagId="36599">
        <name>June 2021 List</name>
      </tag>
      <tag tagId="3817">
        <name>Liossi C</name>
      </tag>
      <tag tagId="25511">
        <name>Mott C</name>
      </tag>
      <tag tagId="25309">
        <name>Opioids</name>
      </tag>
      <tag tagId="8357">
        <name>Oulton K</name>
      </tag>
      <tag tagId="3045">
        <name>Paediatrics</name>
      </tag>
      <tag tagId="1299">
        <name>Pain Management</name>
      </tag>
      <tag tagId="13">
        <name>Palliative Care</name>
      </tag>
      <tag tagId="36709">
        <name>Palliative Medicine.</name>
      </tag>
      <tag tagId="36712">
        <name>Skene SS</name>
      </tag>
      <tag tagId="434">
        <name>Terminal Care</name>
      </tag>
      <tag tagId="36713">
        <name>Wong ICK</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
